Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Snake214on Jun 10, 2018 9:12am
158 Views
Post# 28151279

RE:RE:RE:RE:RE:reverse split

RE:RE:RE:RE:RE:reverse split Isn’t the bigger problem the fact that at current price they are sporting a 170m+ mkt cap and all they have is a big empty building and a cultivation license. Not to mention a 10-1 consolidation....there is no guarantee the price will end up 10x afterwards.  Matter fact history would suggest it will not.
 
And let’s not forget about the super voting rights the common shareholders really can’t even make any decisions. As for cannabis Wheaton. It’ll be hard to get a decent return and any lift selling 1/2 production at cost plus an admin %. 

Personally i I like a tight float with high inside ownership of the same class of shares I’m holding. But that’s just me. GLTA
Bullboard Posts